Naomi Iris van den Berg
@naomiirisvdberg.bsky.social
Postdoctoral Fellow Mathematical Oncology @crick.ac.uk. Former PhD @MRC_TU, Patil Group, Cambridge University and student
@WUR, @niooknaw, @Cornell, @UCUtrecht
@WUR, @niooknaw, @Cornell, @UCUtrecht
More immune cells should mean better outcomes.
Yet in kidney cancer, glioma, uveal melanoma - it doesn’t.
We think tissue metabolism is the missing variable.
Immunometabolic gatekeeping - preprint out now 🔗
arxiv.org/abs/2511.20883
Yet in kidney cancer, glioma, uveal melanoma - it doesn’t.
We think tissue metabolism is the missing variable.
Immunometabolic gatekeeping - preprint out now 🔗
arxiv.org/abs/2511.20883
November 27, 2025 at 9:43 AM
More immune cells should mean better outcomes.
Yet in kidney cancer, glioma, uveal melanoma - it doesn’t.
We think tissue metabolism is the missing variable.
Immunometabolic gatekeeping - preprint out now 🔗
arxiv.org/abs/2511.20883
Yet in kidney cancer, glioma, uveal melanoma - it doesn’t.
We think tissue metabolism is the missing variable.
Immunometabolic gatekeeping - preprint out now 🔗
arxiv.org/abs/2511.20883